Literature DB >> 33867745

Myeloid Neoplasm with t(8;22)(p11;q11): A Mimicker of Chronic Myeloid Leukaemia in Blast Crisis.

Gargi Kapatia1, Arun Sasikumar Nair Remani2, Shano Naseem1, Mayur Parihar2, Sreejesh Sreedharanunni1.   

Abstract

Entities:  

Year:  2020        PMID： 33867745      PMCID： PMC8012448          DOI： 10.1007/s12288-020-01343-3

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  5 in total

1.  Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.

Authors:  T Fioretos; I Panagopoulos; C Lassen; A Swedin; R Billström; M Isaksson; B Strömbeck; T Olofsson; F Mitelman; B Johansson
Journal:  Genes Chromosomes Cancer       Date:  2001-12       Impact factor: 5.006

Review 2.  Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.

Authors:  Ximena Montenegro-Garreaud; Roberto N Miranda; Alexandra Reynolds; Guilin Tang; Sa A Wang; Mariko Yabe; Wei Wang; Lianghua Fang; Carlos E Bueso-Ramos; Pei Lin; L Jeffrey Medeiros; Xinyan Lu
Journal:  Hum Pathol       Date:  2017-05-24       Impact factor: 3.466

3.  Functional characterization of two rare BCR-FGFR1+ leukemias.

Authors:  Evan J Barnes; Jessica Leonard; Bruno C Medeiros; Brian J Druker; Cristina E Tognon
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-04-01

4.  Oncogenic fusion protein BCR-FGFR1 requires the breakpoint cluster region-mediated oligomerization and chaperonin Hsp90 for activation.

Authors:  Malalage N Peiris; April N Meyer; Katelyn N Nelson; Ezra W Bisom-Rapp; Daniel J Donoghue
Journal:  Haematologica       Date:  2019-08-22       Impact factor: 9.941

5.  NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies.

Authors:  Nikhil Patkar; Prasanna Bhanshe; Sweta Rajpal; Swapnali Joshi; Shruti Chaudhary; Gaurav Chatterjee; Prashant Tembhare; Chetan Dhamne; Maya Prasad; Nirmalya Roy Moulik; Dhanalaxmi Shetty; Anant Gokarn; Avinash Bonda; Lingaraj Nayak; Sachin Punatkar; Bhausaheb Bagal; Manju Sengar; Gaurav Narula; Navin Khattry; Shripad Banavali; P G Subramanian; Sumeet Gujral
Journal:  Blood Cancer J       Date:  2020-05-05       Impact factor: 11.037
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.